2024

LinusBio Wins 2024 BioTech Breakthrough Award for “Overall MedTech Company of the Year”

Read more
2025

Groundbreaking Autism Biomarker: LinusBio Launches ClearStrand-ASD to aid Health Care Providers in Ruling Out Autism Using a Single Strand of Hair

2024

LinusBio Bucks Market Slowdown, Secures Additional $8M in A2 Funding with Increased Valuation

2024

LinusBio Named “Fierce 15” Company of 2023 by Fierce Medtech

2023

LinusBio Raises $16 Million to Scale Growth and Deliver Tangible Outcomes

2022

Novozymes and LinusBio announce collaboration to accelerate scientific discovery in Biohealth

LinusBio Recognized at the 2022 Mount Sinai Innovation Awards